The U.S. prostate cancer biomarkers market size was estimated at USD 1.7 billion in 2024 and is expected to grow at a CAGR of 14.74% from 2025 to 2033. The market growth is driven by the rising prevalence of prostate cancer, awareness around early detection, and adoption of precision dia... Read More »
July 2025The U.S. clinical laboratory services market size was estimated at USD 9.42 billion in 2024 and is projected to register a CAGR of 5.07% from 2025 to 2033. The market is primarily driven by the increasing burden of chronic diseases, which has intensified the demand for routine and specia... Read More »
July 2025The U.S. microarray market size was estimated at USD 2.65 billion in 2024 and is projected to grow at a CAGR of 5.7% from 2025 to 2033. The market is driven by the surging demand for personalized medicine, especially in precision oncology and pharmacogenomics. With rising investments fro... Read More »
July 2025The global blood-based biomarker for Parkinson’s disease market size was estimated at USD 117.79 million in 2024 and is projected to reach USD 350.87 million by 2033, growing at a CAGR of 19.25% from 2025 to 2033. The market is exhibiting significant growth driven by rising prevale... Read More »
July 2025The global hemato oncology testing market size was estimated at USD 3.60 billion in 2024 and is projected to reach USD 7.44 billion by 2030, growing at a CAGR of 12.99% from 2025 to 2030. Hemato oncology is associated with the treatment, diagnosis, and prevention of blood-related cancers... Read More »
July 2025The China Alzheimer’s disease diagnostics market was estimated at USD 319.6 million in 2024 and is projected to reach USD 617.8 million by 2030, growing at a CAGR of 11.7% from 2025 to 2030. The increasing prevalence of Alzheimer’s disease (AD), growing adoption of personaliz... Read More »
July 2025The U.S. anatomic pathology market size was estimated at USD 9.71 billion in 2024 and is projected to reach USD 15.35 billion by 2030, growing at a CAGR of 7.1% from 2025 to 2030. This market is experiencing robust growth driven by technological innovation and growing clinical demands.... Read More »
July 2025The U.S. blood-based biomarker for parkinson’s disease market size was estimated at USD 45.75 million in 2024, and is projected to grow at a CAGR of 18.33% from 2025 to 2033. The U.S. Parkinson’s disease (PD) blood-based biomarkers market is driven by a growing patient popula... Read More »
July 2025The U.S. point of care drug of abuse (DOA) testing market size was estimated at USD 370.55 million in 2024 and is projected to grow at a CAGR of 9.3% from 2025 to 2033. The market is driven by an increasing need for rapid and on-site drug testing across multiple settings. Point-of-care D... Read More »
July 2025The U.S. ferritin testing market size was estimated at USD 274.60 million in 2024 and is projected to grow at a CAGR of 5.63% from 2025 to 2033. The market is driven by the rising prevalence of iron deficiency anemia and related chronic conditions such as inflammatory diseases, chronic k... Read More »
July 2025The global point of care drug of abuse testing market size was estimated at USD 1.08 billion in 2024 and is projected to reach USD 2.45 billion by 2033, growing at a CAGR of 9.62% from 2025 to 2033, due to increasing substance misuse worldwide and the urgent need for rapid, decentralized... Read More »
July 2025The global esoteric testing market size was estimated at USD 24.6 billion in 2024 and is projected to reach USD 47.98 billion by 2030, growing at a CAGR of 11.8% from 2025 to 2030. The market growth can be attributed to the increasing demand for early disease diagnosis and the rising pre... Read More »
July 2025The U.S. molecular biology enzymes, reagents and kits market size was estimated at USD 5.95 billion in 2024 and is projected to grow at a CAGR of 9.65% from 2025 to 2033. The market is driven by growing burden of chronic diseases and infectious diseases such as sexually transmitted ... Read More »
June 2025The U.S. lateral flow assay market size was valued at USD 2.82 billion in 2024 and is projected to reach USD 4.63 billion by 2033, growing at a CAGR of 6.08% from 2025 to 2033. The rising prevalence of infectious diseases places immense pressure on public health systems worldwide. With i... Read More »
June 2025The U.S. minimal residual disease testing market was estimated at USD 873.66 million in 2024 and is projected to grow at a CAGR of 9.38% from 2025 and 2033, driven by the country’s rising cancer burden and the healthcare system’s growing emphasis on precision medicine. Accord... Read More »
June 2025The global gastric cancer diagnostics market was estimated at USD 1.18 billion in 2024 and is projected to reach USD 2.22 billion by 2033, growing at a CAGR of 7.43% from 2025 to 2033. The market is growing, driven by the rising incidence of gastric cancer, growing emphasis on early dete... Read More »
June 2025The U.S. gastric cancer diagnostics market size was estimated at USD 489.09 million in 2024 and is projected to reach 897.20 million by 2033, and growing at a CAGR of 7.08% from 2025 to 2033. The U.S. gastric cancer diagnostics market is expanding due to advancements in diagnostic techno... Read More »
June 2025The global pharmaceutical sterility testing market size was estimated at USD 1.75 billion in 2024 and is projected to reach USD 4.64 billion by 2033, growing at a CAGR of 11.58% from 2025 to 2033.Increasing government investments, R&D activities, a growing number of drug launches, an... Read More »
June 2025The U.S. Alzheimer’s disease diagnostics market was valued at USD 3.53 billion in 2024 and is expected to grow at a CAGR of 10.6% from 2025 to 2030. This growth is driven by the rising prevalence of Alzheimer’s disease and increasing emphasis on early and accurate diagnosis. ... Read More »
June 2025The global respiratory syncytial virus vaccines market size was estimated at USD 3.51 billion in 2024 and is projected to reach USD 28.39 billion by 2030, growing at a CAGR of 42.17% from 2025 to 2030, due to the rising burden of respiratory syncytial virus (RSV)-related hospitalizations... Read More »
June 2025